endofocusFOCUS ЭндокринологияFOCUS. Endocrinology2713-01772713-0185ООО "Издательство "Перо"10.15829/1560-4071-2023-15CMOVDKendofocus-15Research ArticleОБЗОР ЛИТЕРАТУРЫLITERATURE REVIEWОсобенности лечения пожилых пациентов с сахарным диабетом 2 типаPecularities of treatment of elderly patients with type 2 diabetes mellitushttps://orcid.org/0000-0001-6385-540XДемидоваТ. Ю.DemidovaT. Yu.

д.м.н., профессор, зав. кафедрой эндокринологии лечебного факультета

Москва

Moscow

fati_2526@mail.ruhttps://orcid.org/0000-0002-6826-5924КочинаА. С.KochinaA. S.

асcистент кафедры эндокринологии лечебного факультета

Москва

Moscow

anna_kochina_@mail.ruФГАОУ ВО Российский национальный исследовательский медицинский университет им. Н. И. Пирогова Минздрава РоссииPirogov Russian National Research Medical University20231005202342Кардиоэндокринология3641Copyright © Демидова Т.Ю., Кочина А.С., 20232023Демидова Т.Ю., Кочина А.С.Demidova T.Y., Kochina A.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://endofocus.elpub.ru/jour/article/view/15

Лечение сахарного диабета у пожилых людей требует тщательного рассмотрения сопутствующих гериатрических синдромов и хронических заболеваний, которые повышают риск осложнений, включая тяжелую гипогликемию. Индивидуализированный подход к лечению пожилых пациентов заключается в установлении менее строгих целей гликемического контроля и контроля сопутствующих заболеваний с учетом нарушения способностей к самообслуживанию, снижения когнитивных способностей, а также снижения зрения. Целями лечения диабета у пожилых людей считаются поддержание качества жизни и сведение к минимуму симптоматической гипергликемии, риска гипогликемии и побочных эффектов лекарств. В связи с этим все большую популярность набирает концепция депрескрайбинга в лечении пожилых пациентов.

The management of diabetes in the elderly requires careful consideration of concomitant geriatric syndromes and chronic diseases that increase the risk of complications, including severe hypoglycemia. An individualized approach to the treatment of elderly patients includes the establishment of less strict goals of glycemic control, blood pressure control, taking into account impaired self-care abilities, cognitive abilities and loss of vision. The goals of diabetes treatment in the elderly are considered to maintain the quality of life and minimize symptomatic hyperglycemia, the risk of hypoglycemia and side effects of medications. In this regard, the concept of deprescribing in the treatment of elderly patients is gaining more and more popularity.

сахарный диабет 2 типапожилые пациентыкоморбидностьсаркопенияиндивидуализированный подходtype 2 diabetes mellituselderly patientscomorbiditysarcopeniaindividualized approachReferencesDyussenbayev A. Age Periods Of Human Life. Advances in Social Sciences Research Journal. 2017;4(6). doi:10.14738/assrj.46.2924.Dyussenbayev A. Age Periods Of Human Life. Advances in Social Sciences Research Journal. 2017;4(6). doi:10.14738/assrj.46.2924.GBD 2019 Demographics Collaborators. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1160-203. doi:10.1016/S0140-6736(20)30977-6.GBD 2019 Demographics Collaborators. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1160-203. doi:10.1016/S0140-6736(20)30977-6.Soriguer F, Goday A, Bosch-Comas A, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Diabetes Study. Diabetologia. 2012;55(1):88-93. doi:10.1007/s00125-011-2336-9.Soriguer F, Goday A, Bosch-Comas A, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Diabetes Study. Diabetologia. 2012;55(1):88-93. doi:10.1007/s00125-011-2336-9.Gómez-Huelgas R, Gómez Peralta F, Rodríguez Mañas L, et al. Tratamiento de la diabetes mellitus tipo 2 en el paciente anciano. Rev Esp Geriatr Gerontol. 2018;53(2):89-99. doi:10.1016/j.regg.2017.12.003.Gómez-Huelgas R, Gómez Peralta F, Rodríguez Mañas L, et al. Tratamiento de la diabetes mellitus tipo 2 en el paciente anciano. Rev Esp Geriatr Gerontol. 2018;53(2):89-99. doi:10.1016/j.regg.2017.12.003.Mooradian AD. Evidence-Based Management of Diabetes in Older Adults. Drugs Aging. 2018;35(12):1065-78. doi:10.1007/s40266-018-0598-3.Mooradian AD. Evidence-Based Management of Diabetes in Older Adults. Drugs Aging. 2018;35(12):1065-78. doi:10.1007/s40266-018-0598-3.Scheen AJ. Diabetes mellitus in the elderly: insulin resistance and/ or impaired insulin secretion? Diabetes Metab. 2005;31(spec no 2):5S27-5S34.Scheen AJ. Diabetes mellitus in the elderly: insulin resistance and/ or impaired insulin secretion? Diabetes Metab. 2005;31(spec no 2):5S27-5S34.Chiu KC, Lee NP, Cohan PC, Chuang LM. Beta cell function declines with age in glucose tolerant Caucasians. Clin Endocrinol (Oxf). 2000;53(5):569-75.Chiu KC, Lee NP, Cohan PC, Chuang LM. Beta cell function declines with age in glucose tolerant Caucasians. Clin Endocrinol (Oxf). 2000;53(5):569-75.Novelli M, De Tata V, Bombara M, et al. Age-dependent reduction in GLUT-2 levels is correlated with the impairment of the insulin secretory response in isolated islets of Sprague-Dawley rats. Exp Gerontol. 2000;35(5):641-51.Novelli M, De Tata V, Bombara M, et al. Age-dependent reduction in GLUT-2 levels is correlated with the impairment of the insulin secretory response in isolated islets of Sprague-Dawley rats. Exp Gerontol. 2000;35(5):641-51.Cnop M, Grupping A, Hoorens A, et al. Endocytosis of low-density lipoprotein by human pancreatic beta cells and uptake in lipid-storing vesicles, which increase with age. Am J Pathol. 2000;156(1):237-44.Cnop M, Grupping A, Hoorens A, et al. Endocytosis of low-density lipoprotein by human pancreatic beta cells and uptake in lipid-storing vesicles, which increase with age. Am J Pathol. 2000;156(1):237-44.Haataja L, Gurlo T, Huang CJ, Butler PC. Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr Rev. 2008;29(3):303-16.Haataja L, Gurlo T, Huang CJ, Butler PC. Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr Rev. 2008;29(3):303-16.Benjamin EJ, Muntner P, Bittencourt MS, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139:e56-e528. doi:10.1161/CIR.0000000000000659.Benjamin EJ, Muntner P, Bittencourt MS, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139:e56-e528. doi:10.1161/CIR.0000000000000659.Ciumărnean L, Milaciu MV, Negrean V, et al. Cardiovascular Risk Factors and Physical Activity for the Prevention of Cardiovascular Diseases in the Elderly. Int J Environ Res Public Health. 2021;19(1):207. doi:10.3390/ijerph19010207.Ciumărnean L, Milaciu MV, Negrean V, et al. Cardiovascular Risk Factors and Physical Activity for the Prevention of Cardiovascular Diseases in the Elderly. Int J Environ Res Public Health. 2021;19(1):207. doi:10.3390/ijerph19010207.Pratley RE, Gilbert M. Clinical management of elderly patients with type 2 diabetes mellitus. Postgrad Med. 2012;124(1):133-43. doi:10.3810/pgm.2012.01.2526.Pratley RE, Gilbert M. Clinical management of elderly patients with type 2 diabetes mellitus. Postgrad Med. 2012;124(1):133-43. doi:10.3810/pgm.2012.01.2526.Sinclair AJ, Rodriguez-Mañas L. Diabetes and Frailty: Two Converging Conditions? Can. J. Diabetes. 2016;40:77-83. doi:10.1016/j.jcjd.2015.09.004.Sinclair AJ, Rodriguez-Mañas L. Diabetes and Frailty: Two Converging Conditions? Can. J. Diabetes. 2016;40:77-83. doi:10.1016/j.jcjd.2015.09.004.Rolland Y, Czerwinski S, Abellan Van Kan G, et al. Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives. J. Nutr. Health Aging. 2008;12:433-50. doi:10.1007/BF02982704.Rolland Y, Czerwinski S, Abellan Van Kan G, et al. Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives. J. Nutr. Health Aging. 2008;12:433-50. doi:10.1007/BF02982704.Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591-604. doi:10.1038/s41574-018-0048-7.Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591-604. doi:10.1038/s41574-018-0048-7.Volkert D, Beck AM, Cederholm T, et al. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin. Nutr. 2019;38:10-47. doi:10.1016/j.clnu.2018.05.024.Volkert D, Beck AM, Cederholm T, et al. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin. Nutr. 2019;38:10-47. doi:10.1016/j.clnu.2018.05.024.Bauer J, Biolo G, Cederholm T, et al. Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group. J. Am. Med Dir. Assoc. 2013;14:542-59. doi:10.1016/j.jamda.2013.05.021.Bauer J, Biolo G, Cederholm T, et al. Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group. J. Am. Med Dir. Assoc. 2013;14:542-59. doi:10.1016/j.jamda.2013.05.021.Tamura Y, Omura T, Toyoshima K, Araki A. Nutrition Management in Older Adults with Diabetes: A Review on the Importance of Shifting Prevention Strategies from Metabolic Syndrome to Frailty. Nutrients. 2020;12:3367. doi:10.3390/nu12113367.Tamura Y, Omura T, Toyoshima K, Araki A. Nutrition Management in Older Adults with Diabetes: A Review on the Importance of Shifting Prevention Strategies from Metabolic Syndrome to Frailty. Nutrients. 2020;12:3367. doi:10.3390/nu12113367.Kwok T, Lee J, Ma RC, et al. A randomized placebo controlled trial of vitamin B12 supplementation to prevent cognitive decline in older diabetic people with borderline low serum vitamin B12. Clin. Nutr. 2017;36:1509-15. doi:10.1016/j.clnu.2016.10.018.Kwok T, Lee J, Ma RC, et al. A randomized placebo controlled trial of vitamin B12 supplementation to prevent cognitive decline in older diabetic people with borderline low serum vitamin B12. Clin. Nutr. 2017;36:1509-15. doi:10.1016/j.clnu.2016.10.018.Narayana S, Dass AS, Venkatarathnamma PN. Effect of Vitamin E and omega 3 fatty acids in type 2 diabetes mellitus patients. J. Adv. Pharm. Technol. Res. 2018;9:32-6. doi:10.4103/japtr.JAPTR_309_17.Narayana S, Dass AS, Venkatarathnamma PN. Effect of Vitamin E and omega 3 fatty acids in type 2 diabetes mellitus patients. J. Adv. Pharm. Technol. Res. 2018;9:32-6. doi:10.4103/japtr.JAPTR_309_17.Okamura T, Hashimoto Y, Miki A, et al. Reduced dietary omega-3 fatty acids intake is associated with sarcopenia in elderly patients with type 2 diabetes: A crosssectional study of KAMOGAWA-DM cohort study. J. Clin. Biochem. Nutr. 2020;66:233-7. doi:10.3164/jcbn.19-85.Okamura T, Hashimoto Y, Miki A, et al. Reduced dietary omega-3 fatty acids intake is associated with sarcopenia in elderly patients with type 2 diabetes: A crosssectional study of KAMOGAWA-DM cohort study. J. Clin. Biochem. Nutr. 2020;66:233-7. doi:10.3164/jcbn.19-85.Jayanama K, Theou O, Godin J, et al. Association of fatty acid consumption with frailty and mortality among middle-aged and older adults. Nutrition. 2020;70:110610. doi:10.1016/j.nut.2019.110610.Jayanama K, Theou O, Godin J, et al. Association of fatty acid consumption with frailty and mortality among middle-aged and older adults. Nutrition. 2020;70:110610. doi:10.1016/j.nut.2019.110610.Kojima G, Avgerinou C, Iliffe S, Walters K. Adherence to Mediterranean Diet Reduces Incident Frailty Risk: Systematic Review and Meta-Analysis. J. Am. Geriatr. Soc. 2018;66:783-8. doi:10.1111/jgs.15251.Kojima G, Avgerinou C, Iliffe S, Walters K. Adherence to Mediterranean Diet Reduces Incident Frailty Risk: Systematic Review and Meta-Analysis. J. Am. Geriatr. Soc. 2018;66:783-8. doi:10.1111/jgs.15251.Amati F, Dube JJ, Coen PM, et al. Physical inactivity and obesity underlie the insulin resistance of aging. Diabetes Care. 2009;328:1547-9.Amati F, Dube JJ, Coen PM, et al. Physical inactivity and obesity underlie the insulin resistance of aging. Diabetes Care. 2009;328:1547-9.Cox JH, Cortright RN, Dohm GL, Houmard JA. Effect of aging on response to exercise training in humans: skeletal muscle GLUT-4 and insulin sensitivity. J Appl Physiol. 1999;86:2019-25.Cox JH, Cortright RN, Dohm GL, Houmard JA. Effect of aging on response to exercise training in humans: skeletal muscle GLUT-4 and insulin sensitivity. J Appl Physiol. 1999;86:2019-25.Short KR, Vittone JL, Bigelow ML, et al. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes. 2003;52:1888-96.Short KR, Vittone JL, Bigelow ML, et al. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes. 2003;52:1888-96.Hovanec N, Sawant A, Overend TJ, et al. Resistance training and older adults with type 2 diabetes mellitus: strength of the evidence. J Aging Res. 2012;2012:284635.Hovanec N, Sawant A, Overend TJ, et al. Resistance training and older adults with type 2 diabetes mellitus: strength of the evidence. J Aging Res. 2012;2012:284635.Sanz-Cánovas J, López-Sampalo A, Cobos-Palacios L, et al. Management of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or Sarcopenia. Int J Environ Res Public Health. 2022;19(14):8677. doi:10.3390/ijerph19148677.Sanz-Cánovas J, López-Sampalo A, Cobos-Palacios L, et al. Management of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or Sarcopenia. Int J Environ Res Public Health. 2022;19(14):8677. doi:10.3390/ijerph19148677.LeRoith D, Biessels GJ, Braithwaite SS, et al. Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. 2019;104(5):1520-74. doi:10.1210/jc.2019-00198.LeRoith D, Biessels GJ, Braithwaite SS, et al. Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. 2019;104(5):1520-74. doi:10.1210/jc.2019-00198.Дедов И. И., Шестакова М. В., Майоров А. Ю. и др. "Алгоритмы специализированной медицинской помощи больным сахарным диабетом". Под редакцией И. И. Дедова, М. В. Шестаковой, А. Ю. Майорова. 10-й выпуск. Сахарный диабет. 2021;24(1S):1-148. doi:10.14341/DM12802.Дедов И. И., Шестакова М. В., Майоров А. Ю. и др. "Алгоритмы специализированной медицинской помощи больным сахарным диабетом". Под редакцией И. И. Дедова, М. В. Шестаковой, А. Ю. Майорова. 10-й выпуск. Сахарный диабет. 2021;24(1S):1-148. doi:10.14341/DM12802.Wallia A, Molitch ME. Insulin therapy for type 2 diabetes mellitus. JAMA. 2014;311(22):2315-25.Wallia A, Molitch ME. Insulin therapy for type 2 diabetes mellitus. JAMA. 2014;311(22):2315-25.Flory J, Lipska K. Metformin in 2019. JAMA. 2019;321(19):1926-7. doi:10.1001/jama.2019.3805.Flory J, Lipska K. Metformin in 2019. JAMA. 2019;321(19):1926-7. doi:10.1001/jama. 2019.3805.Nesto RW, Bell D, Bonow RO, et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Diabetes Care. 2004;27(1):256-63.Nesto RW, Bell D, Bonow RO, et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Diabetes Care. 2004;27(1):256-63.Choi HJ, Park C, Lee YK, et al. Risk of fractures and diabetes medications: a nationwide cohort study. Osteoporos Int. 2016;27(9):2709-15.Choi HJ, Park C, Lee YK, et al. Risk of fractures and diabetes medications: a nationwide cohort study. Osteoporos Int. 2016;27(9):2709-15.Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377(7):644-57.Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377(7):644-57.Thomsen RW, Pedersen L, Møller N, et al. Incretin-based therapy and risk of acute pancreatitis: a nationwide population-based case-control study. Diabetes Care. 2015;38(6):1089-98.Thomsen RW, Pedersen L, Møller N, et al. Incretin-based therapy and risk of acute pancreatitis: a nationwide population-based case-control study. Diabetes Care. 2015;38(6):1089-98.Zaccardi F, Htike ZZ, Webb DR, et al. Benefits and harms of once-weekly glucagon-like peptide-1 receptor agonist treatments: a systematic review and network meta-analysis. Ann Intern Med. 2016;164(2):102-13.Zaccardi F, Htike ZZ, Webb DR, et al. Benefits and harms of once-weekly glucagon-like peptide-1 receptor agonist treatments: a systematic review and network meta-analysis. Ann Intern Med. 2016;164(2):102-13.Pirela DV, Garg R. De-intensification of diabetes treatment in elderly patients with type 2 diabetes mellitus. Endocr Pract. 2019;25(12):1317-22. doi:10.4158/EP-2019-0303.Pirela DV, Garg R. De-intensification of diabetes treatment in elderly patients with type 2 diabetes mellitus. Endocr Pract. 2019;25(12):1317-22. doi:10.4158/EP-2019-0303.

The authors declare that there are no conflicts of interest present.